MRCVX | VASIX | MRCVX / VASIX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 11 years | 30 years | - |
Gain YTD | 0.000 | 0.000 | - |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 181M | 4.01B | 5% |
Annual Yield % from dividends | 2.80 | 3.30 | 85% |
Returns for 1 year | 4.56 | 2.55 | 179% |
Returns for 3 years | -5.00 | -4.58 | 109% |
Returns for 5 years | 0.90 | 2.21 | 41% |
Returns for 10 years | 15.29 | 23.59 | 65% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
BLNAX | 12.63 | N/A | N/A |
Meeder Balanced Adviser | |||
LRMAX | 23.07 | -0.04 | -0.17% |
Lord Abbett Dividend Growth F3 | |||
ABCRX | 20.87 | -0.10 | -0.48% |
American Beacon The London Co Inc Eq R6 | |||
AMAEX | 10.67 | -0.08 | -0.74% |
American Century Small Cap Dividend Inv | |||
MDNAF | 1.12 | -0.03 | -2.62% |
Medicenna Therapeutics Corp. |